Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

The one chart that should scare Snapchat investors

User growth has been rapidly decelerating.

Snapchat CEO Evan Spiegel speaks onstage during ‘Disrupting Information and Communication’ at the Vanity Fair New Establishment Summit at Yerba Buena Center for the Arts on October 8, 2014 in San Francisco, California.
Snapchat CEO Evan Spiegel speaks onstage during ‘Disrupting Information and Communication’ at the Vanity Fair New Establishment Summit at Yerba Buena Center for the Arts on October 8, 2014 in San Francisco, California.
Michael Kovac / Getty Images for Vanity Fair

Snap’s IPO filing reveals a startling trend: While Snapchat, its flagship product, is still growing — as measured by daily active users — its growth has rapidly decelerated over the past year.

Specifically, Snap’s quarterly gain in average DAUs decreased to five million during the fourth quarter of 2016, down from a peak of 21 million in the second quarter and 10 million in the third quarter.

In its filing, Snap depicts its user growth in a bar chart of its average DAUs, which shows “up-and-to-the-right” growth, albeit at a slower rate throughout 2016.

But here’s another way to look at it, just isolating the growth. It’s easier to see the deceleration this way.

In its filing, Snap notes that its growth in December was better than the first two months of the fourth quarter, when “flat growth ... was primarily related to accelerated growth in user engagement earlier in the year, diminished product performance and increased competition.”

Snap goes into greater detail about each of these issues. But the most interesting question is around competition. (Snap’s description: “We also saw increased competition both domestically and internationally in 2016, as many of our competitors launched products with similar functionality to ours.”)

Mostly, that means competition from Facebook-owned Instagram, which cloned Snapchat’s popular “Stories” feature in August, early in the third quarter, which is also when Snap’s momentum started to fall off a cliff.

So that’s the big question: Will Snap be able to use its ingenuity to re-accelerate the growth of its network over 2017? Or have Instagram and other competitors — such as Snow, an Asian Snapchat clone — effectively neutralized it?


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh